Dihydropteridine reductase (DHPR; EC 1.6.99.7) catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin and is an essential component of the pterindependent aromatic amino acid hydroxylating systems. A cDNA for human DHPR was isolated from a human liver cDNA library in the vector Kgtll using a monospecific antibody against sheep DHPR. The nucleic acid sequence and amino acid sequence of human DHPR were determined from a full-length clone. A 112 amino acid sequence of sheep DHPR was obtained by sequencing purified sheep DHPR. This sequence is highly homologous to the predicted amino acid sequence of the human protein. Gene transfer of the recombinant human DHPR into COS cells leads to expression of DHPR enzymatic activity.
Tetrahydrobiopterin (BH4) is the essential coenzyme for three aromatic amino acid hydroxylases (1, 2) that have important biochemical and physiological functions in higher eukaryotes (2) . Tyrosine hydroxylase catalyzes the conversion of tyrosine to dihydroxyphenylalanine, which is a rate-limiting step in the synthesis of catecholamines. Tryptophan hydroxylase catalyzes the conversion of tryptophan to 5-hydroxytryptophan, which is a rate-limiting step in the synthesis of serotonin. Phenylalanine hydroxylase catalyzes the conversion of phenylalanine to tyrosine, which is an obligatory step in the degradation ofphenylalanine. Deficiency of phenylalanine hydroxylase causes the disease phenylketonuria in which phenylalanine accumulation leads to a syndrome of mental retardation (3, 4) . All three pterindependent hydroxylases catalyze coupled reactions in which the aromatic amino acid is hydroxylated and the tetrahydropterin is oxidized to the corresponding quinonoid dihydropterin (2) (3) (4) (5) .
The naturally occurring biopterin cofactor BH4 (1) is synthesized from GTP (6) and is maintained in its reduced form by the enzyme dihydropteridine reductase (DHPR; EC 1.6.99.7) (5, 7). DHPR catalyzes the reduction of quinonoid dihydrobiopterin to BH4 (5) utilizing a reduced pyridine nucleotide as the electron donor. Both NADPH and NADH are active (7) , though NADH is the preferred cofactor (8) (9) (10) .
Genetic deficiency of DHPR has been described in several individuals who were found to have hyperphenylalaninemia by routine newborn screening for phenylketonuria but suffered from severe mental retardation that was refractory to dietary therapy (11) (12) (13) . These individuals had deficiencies of phenylalanine hydroxylase, tyrosine hydroxylase, and tryptophan hydroxylase secondary to the absence of DHPR (3, 4, 11) .
DHPR is a ubiquitous enzyme in higher eukaryotes and has been purified to homogeneity from many sources (9, 10, (14) (15) (16) . The enzyme is a dimeric protein consisting of two identical peptides whose molecular mass is variously reported between 21,000 and 27,000 Da (2, 3). The amino acid compositions of sheep, bovine, and human DHPR have been reported (9, 10, (14) (15) (16) .
In this report we describe cloning and sequencing of a full-length cDNA for human DHPR, partial sequencing of purified sheep DHPR, and constitution of human DHPR enzymatic activity by genetic transfer of the cDNA clone.
MATERIALS AND METHODS
Purification and Sequencing of Sheep DHPR. The purification of DHPR from sheep liver and the preparation of a monospecific anti-sheep DHPR antiserum has been described (9, 17) . Protein was cleaved with CNBr and fragments were isolated and sequenced on an Applied Biosystems (Foster City, CA) 470A gas-phase protein sequencer as described (18) .
Identification of cDNA Clones for Human DHPR. A human liver cDNA library in the expression vector Xgtll (19) was screened with monospecific antibody against sheep DHPR using methods previously described (20, 21) . The library was rescreened with 32P-labeled fragments of the DHPR cDNA (19) . Two EcoRI fragments from clone hDHPR1 were used to hybrid-select mRNA from liver poly(A)+ RNA (22) . Hybridselected mRNA was translated in the presence of [35S]methionine using a rabbit reticulocyte lyase system (New England Nuclear). Proteins were immunoprecipitated using anti-sheep DHPR antibody and analyzed by NaDodSO4/ polyacrylamide gel electrophoresis.
DNA-Mediated Gene Transfer and Assay of DHPR. The full-length cDNA insert from clone hDHPR13 was isolated by partial EcoRI digestion and subcloned into the expression vector p91023B provided by Randy Kaufman (Genetics Institute, Boston, MA) (23) . Clones were obtained with the DHPR sequence in the sense orientation [91023B-DHPR(+)] or in the antisense orientation [91023B-DHPR(-)]. These clones were transfected into COS cells (24) by calcium phosphate precipitation (25, 26) to achieve transient expression of the recombinant gene (27) . Cytoplasmic extracts were prepared 72 hr after transfection and assayed for DHPR activity as described (17 DNA Sequencing and Sequence Analysis. DNA sequence was determined by using the dideoxy chain-termination method of Sanger et al. (28) . Computer analysis of the cDNA and predicted protein sequences were performed using the on-line facilities of the Protein Identification Resource (PIR), the PIR, GENBANK, and European Molecular Biology Laboratory (EMBL) data bases, and the FASTP, SEARCH, and ALIGN programs (29) .
RESULTS
Identification of Human DHPR Clones. One million plaques from a human liver cDNA library in the vector Xgtll were screened for DHPR-immunoreactive protein using rabbit anti-sheep DHPR antibody (17) . One positive clone was identified. This clone, hDHPR1, contained two internal EcoRI fragments of 710 and 573 bases.
Hybrid selection was performed to purify mRNA corresponding to each of the EcoRI fragments. 25, 774 Da. This is consistent with the 26,000 Da of human DHPR reported (14) . The amino acid composition predicted by the ORV agrees with the amino acid compositions of human, sheep, and bovine DHPR reported (9, 10, 14-16) ( (Fig. 4 Lower). Substantially higher levels of DHPR activity were present in cells transformed with the expression vector containing the hDHPR13 cDNA in the sense orientation (Fig. 4 The fact that genetic transfer of the DHPR clone results in a stop codon. The first AUG is at position 81, and the amino expression of DHPR enzymatic activity suggests that this acid composition of the reading frame from position 81 to 812 clone is a "full-length" cDNA and contains the complete corresponds to the reported amino acid compositions of ORF. The ORF was established at the 3' end of the clone by purified human, sheep, and bovine DHPR. Another AUG is the identity between the sheep DHPR protein sequence and present in a different reading frame at position 11; however, predicted sequence of human DHPR. The integrity of the this frame is interrupted by a TAA stop codon after only 7 Table 1 . Amino acid composition of DHPR amino acids. None of the 40 clones examined extended further at the 5' end than hDHPR1; therefore, we believe that the AUG at position 81 represents the authentic initiation codon. The absence of termination codons 5' to this AUG codon was fortuitous in that the full length of the DHPR protein was apparently produced as a fusion product with P-galactosidase by clone DHPR1. This fusion protein was the only protein detected by screening one million plaques with the anti-sheep DHPR antibody. The amino acid sequence predicted from the ORF of the cDNA clones is highly homologous to the amino acid sequence of sheep DHPR. The differences between these sequences are consistent with the evolutionary distance between sheep and human (31) . We searched the PIR, GENBANK, and EMBL data bases using the FASTP and SEARCH programs of PIR and were unable to identify any sequence homologies to the predicted sequence of DHPR. This result was somewhat surprising since two other enzymes, dihydrofolate reductase (DHFR) and methylenetetrahydrofolate reductase (MTFR), have analogous activities. Genetics: Lockyer et al.
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ly, the analogous activities may reflect convergent evolution of two distinct sequences that have evolved analogous functions from different origins (35) . We did observe similarities in the sequences of DHPR and DHFR in regions known to comprise the binding sites for methotrexate and the pyridine nucleotide cofactor in DHFR. These residues have been identified by crystallography of two prokaryotic DHFR proteins (Escherichia coli and Lactobacillus casei) (36) (37) (38) . Fig. 5 shows an alignment of fragments ofDHPR with residues ofDHFR that contribute to methotrexate and pyridine nucleotide binding. Considerable variation is apparent among the DHFR sequences that are apparently compatible with activity of the enzyme. The aligned fragments of DHPR contain many residues that are identical or functionally analogous to residues in the aligned DHFR sequences and may represent determinants for analogous functions.
The demonstration that DHPR enzymatic activity can be constituted by DNA-mediated gene transfer of the DHPR cDNA will enable experiments aimed at exploring the structure activity relationships of DHPR. Genetic transfer of DHPR may also enable experiments in somatic gene therapy for DHPR deficiency and phenylketonuria. Somatic gene therapy of DHPR deficiency would entail genetic transfer of DHPR into various cells in the body to reconstitute pathways required for aromatic amino acid hydroxylation (39, 40) . Such therapy may be complicated by the necessity for replacing this enzymatic function in cells ofthe central nervous system. DHPR may also be useful in the therapy of phenylketonuria as an adjuvant to reconstitution of the phenylalanine hydroxylase holoenzyme by gene replacement (41, 42) .
